83 FR 30938 - Agency Forms Undergoing Paperwork Reduction Act Review
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention Federal Register Volume 83, Issue 127 (July 2, 2018)
Centers for Disease Control and Prevention
Federal Register Volume 83, Issue 127 (July 2, 2018)
| Page Range | 30938-30940 | |
| FR Document | 2018-14172 |
[Federal Register Volume 83, Number 127 (Monday, July 2, 2018)] [Notices] [Pages 30938-30940] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2018-14172] ======================================================================= ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30Day-18-18CV] Agency Forms Undergoing Paperwork Reduction Act Review In accordance with the Paperwork Reduction Act of 1995, the Centers for Disease Control and Prevention (CDC) has submitted the information collection request titled Rapid Response Suicide Investigation Data Collection to the Office of Management and Budget (OMB) for review and approval. CDC previously published a ``Proposed Data Collection Submitted for Public Comment and Recommendations'' notice on November 9, 2017 to obtain comments from the public and affected agencies. CDC did not receive comments related to the previous notice. This notice serves to allow an additional 30 days for public and affected agency comments. CDC will accept all comments for this proposed information collection project. The Office of Management and Budget is particularly interested in comments that: [[Page 30939]] (a) Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (b) Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (c) Enhance the quality, utility, and clarity of the information to be collected; (d) Minimize the burden of the collection of information on those who are to respond, including, through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses; and (e) Assess information collection costs. To request additional information on the proposed project or to obtain a copy of the information collection plan and instruments, call (404) 639-7570 or send an email to omb@cdc.gov. Direct written comments and/or suggestions regarding the items contained in this notice to the Attention: CDC Desk Officer, Office of Management and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202) 395-5806. Provide written comments within 30 days of notice publication. Proposed Project Rapid Response Suicide Investigation Data Collection--New--National Center for Injury Prevention and Control (NCIPC), Centers for Disease Control and Prevention (CDC) Background and Brief Description CDC is frequently called upon to respond to urgent requests from one or more external partners (e.g., local, state, territory, and tribal health authorities; other federal agencies; local and state leaders; schools; or other partner organizations) to conduct investigations of suicide. Supporting rapid investigations to inform the implementation of effective suicide prevention strategies is one of the most important ways CDC can serve to protect and promote the health of the public. Prior to this request, CDC had collected data for a suicide investigation via the OMB-approved Emergency Epidemic Investigations (EEI) ICR (OMB No. 0920-1011; expiration 3/31/2020), which supported data collections for Epi-Aid investigations. However, this mechanism is no longer available for rapid suicide responses due to the narrowing in scope of that generic. CDC requests approval for a 3-year period for this Generic Information Collection Request to rapidly respond to urgent requests for CDC assistance to investigate an apparent and unexplained potential cluster or increase in suicidal behavior. Rapid Response Suicide Investigation Data Collections are specifically designed to inform the implementation of prevention strategies in a state, county, community, or vulnerable population where a possible suicide cluster or increasing trend has been observed. This generic clearance will not be used to conduct research studies or to collect data designed to draw conclusions about the United States or areas beyond the defined geographic location or vulnerable population that is the focus of the investigation. These public health data are used by external partners (e.g., local, state, territory, and tribal health authorities; other federal agencies; local and state leaders; schools; or other partner organizations) to identify, prioritize, and implement strategies to prevent suicidal behavior and suicide. Rapid Response Suicide Investigation Data Collections methods will vary and depend on the unique circumstances of the urgent and rapid response and objectives determined by CDC. Investigations may use descriptive and/or cohort- or case-control designs. Data collection modes may include: (a) Archival record abstraction; (b) face-to-face interview; (c) telephone interview; (d) web-based questionnaire; (e) self-administered questionnaire; and (f) focus groups. Multiple data collection designs and modes are likely to be employed in a single investigation. The subpopulation will vary and depend on the unique circumstances of the Rapid Response Suicide Investigation Data Collections. Requests for assistance may include a state, county, community, or vulnerable population. Suicide rates are increasing across age-groups and vulnerable populations, include, but are not limited to, youth, middle- aged adults, active duty service personnel, veterans, and American Indian/Alaska Native communities. Investigations likely will often require collection of information from 10 or more respondents. The data analytic approach for the Rapid Response Suicide Investigation Data Collection will vary and depend on the objectives and methods of the investigation. Multiple analytical strategies are likely to be employed in a single investigation. This may include descriptive analyses, logistic regression, and temporal and spatial cluster analyses. The goal of the analyses is to inform suicide prevention strategies by understanding (a) significant increases in fatal or nonfatal suicidal behavior; (b) the risk factors associated with trends of fatal or nonfatal suicidal behavior; (c) the groups most affected (e.g., gender, age, location in community or state); and (d) current risk and protective factors and prevention opportunities. The total estimated annualized burden for this collection is 1,000 hours. The only cost to respondents will be time spent responding to the surveys. Estimated Annualized Burden Hours ---------------------------------------------------------------------------------------------------------------- Number of Average burden Type of respondents Form name Number of responses per per response respondents respondent (in hours) ---------------------------------------------------------------------------------------------------------------- Rapid Response Suicide Investigation Rapid Response Suicide 2,000 1 30/60 Data Collection Participants. Investigation Data Collection Instruments. ---------------------------------------------------------------------------------------------------------------- [[Page 30940]] Jeffrey M. Zirger, Acting Chief, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2018-14172 Filed 6-29-18; 8:45 am] BILLING CODE 4163-18-P
![30938 Federal Register / Vol. 83, No. 127 / Monday, July 2, 2018 / Notices
qualified candidates to apply to be to terms of either 2 or 4 years with the information including name, return
considered for appointment to the possibility of membership renewals as address, email address, and daytime
Committee. appropriate. Membership is limited to telephone number of the nominee and
DATES: Applicable: July 2, 2018. the specific individuals appointed and nominator. GSA will consider
is non-transferrable. Members are nominations of all qualified individuals
FOR FURTHER INFORMATION CONTACT: Mr.
expected to attend all meetings in to ensure that the Committee includes
Ken Sandler, Office of Federal High-
person, review all Committee materials, the areas of high-performance building
Performance Buildings, GSA, 202–219–
and actively provide their advice and subject matter expertise needed. GSA
1121.
input on topics covered by the reserves the right to choose Committee
SUPPLEMENTARY INFORMATION: Committee. Committee members will members based on qualifications,
Background not receive compensation or travel experience, Committee balance,
reimbursements from the Government statutory requirements and all other
The Administrator of the GSA
except where need has been factors deemed critical to the success of
established the Green Building Advisory
demonstrated and funds are available. the Committee. Candidates may be
Committee (hereafter, ‘‘the Committee’’) Request for membership nominations: asked to provide detailed financial
on June 20, 2011 (76 FR 118) pursuant This notice provides an opportunity for information to permit evaluation of
to Section 494 of the Energy individuals to present their potential conflicts of interest that could
Independence and Security Act of 2007 qualifications and apply for an open impede their work on the Committee, in
(42 U.S.C. 17123, or EISA), in seat on the Committee. GSA will ask accordance with the requirements of
accordance with the provisions of the Committee members whose terms are FACA. All nominations must be
Federal Advisory Committee Act expiring to re-apply if they are submitted in sufficient time to be
(FACA), as amended (5 U.S.C. App. 2). interested in continuing to serve on the received by 5 p.m., Eastern Daylight
Under this authority, the Committee Committee. GSA will review all Time (EDT), on Thursday, July 26, 2018,
advises GSA on how the Office of applications and determine which and be addressed to ken.sandler@
Federal High-Performance Buildings can candidates are likely to add the most gsa.gov.
most effectively accomplish its mission. value to the Committee based on the
Extensive information about the Dated: June 27, 2018.
criteria outlined in this notice. Kevin Kampschroer,
Committee, including current members, At a minimum, prospective members
is available on GSA’s website at http:// must have: Federal Director, Office of Federal High-
www.gsa.gov/gbac. Performance Buildings, Office of Government-
Membership requirements: The EISA —At least 5 years of high-performance wide Policy.
statute authorizes the Committee and building experience, which may [FR Doc. 2018–14200 Filed 6–29–18; 8:45 am]
identifies the categories of members to include a combination of project- BILLING CODE 6820–14–P
be included. EISA names 10 federal based, research and policy
agencies and offices to be represented experience.
on the Committee, and GSA works —Academic degrees, certifications and/
directly with these agencies to identify or training demonstrating high- DEPARTMENT OF HEALTH AND
their qualified representatives. This performance building and related HUMAN SERVICES
notice is focused exclusively on non- sustainability and real estate
expertise. Centers for Disease Control and
federal members. EISA provides that, in Prevention
addition to its required federal —Knowledge of federal sustainability
members, the Committee shall include and energy laws and programs.
—Proven ability to work effectively in a [30Day–18–18CV]
‘‘other relevant agencies and entities, as
determined by the Federal Director.’’ collaborative, multi-disciplinary
Agency Forms Undergoing Paperwork
These are to include at least one environment and add value to the
Reduction Act Review
representative of each of the following work of a committee.
—Qualifications appropriate to specific In accordance with the Paperwork
categories:
‘‘(i) State and local governmental statutory requirements (listed above). Reduction Act of 1995, the Centers for
green building programs; No person who is a federally- Disease Control and Prevention (CDC)
(ii) Independent green building registered lobbyist may serve on the has submitted the information
associations or councils; Committee, in accordance with the collection request titled Rapid Response
(iii) Building experts, including Presidential Memorandum ‘‘Lobbyists Suicide Investigation Data Collection to
architects, material suppliers, and on Agency Boards and Commissions’’ the Office of Management and Budget
construction contractors; (June 18, 2010). (OMB) for review and approval. CDC
(iv) Security advisors focusing on Nomination process for Advisory previously published a ‘‘Proposed Data
national security needs, natural Committee appointment: There is no Collection Submitted for Public
disasters, and other dire emergency prescribed format for the nomination. Comment and Recommendations’’
situations; Individuals may nominate themselves notice on November 9, 2017 to obtain
(v) Public transportation industry or others. A nomination package shall comments from the public and affected
experts; and include the following information for agencies. CDC did not receive comments
(vi) Environmental health experts, each nominee: (1) A letter of nomination related to the previous notice. This
including those with experience in stating the name and organizational notice serves to allow an additional 30
daltland on DSKBBV9HB2PROD with NOTICES
children’s health.’’ affiliation(s) of the nominee, days for public and affected agency
EISA further specifies: ‘‘the total membership capacity he/she will serve comments.
number of non-federal members on the (per statutory categories above), CDC will accept all comments for this
Committee at any time shall not exceed nominee’s field(s) of expertise, and proposed information collection project.
15.’’ description of interest and The Office of Management and Budget
Member responsibilities: Approved qualifications; (2) A professional resume is particularly interested in comments
Committee members will be appointed or CV; and (3) Complete contact that:
VerDate Sep<11>2014 17:40 Jun 29, 2018 Jkt 244001 PO 00000 Frm 00030 Fmt 4703 Sfmt 4703 E:\FR\FM\02JYN1.SGM 02JYN1](https://thefederalregister.org/doc/83_FR_31065/page/1.svg)
![30940 Federal Register / Vol. 83, No. 127 / Monday, July 2, 2018 / Notices
Jeffrey M. Zirger, the docket unchanged. Because your claimed confidential information
Acting Chief, Office of Scientific Integrity, comment will be made public, you are redacted/blacked out, will be available
Office of the Associate Director for Science, solely responsible for ensuring that your for public viewing and posted on
Office of the Director, Centers for Disease comment does not include any https://www.regulations.gov. Submit
Control and Prevention. confidential information that you or a both copies to the Dockets Management
[FR Doc. 2018–14172 Filed 6–29–18; 8:45 am] third party may not wish to be posted, Staff. If you do not wish your name and
BILLING CODE 4163–18–P such as medical information, your or contact information to be made publicly
anyone else’s Social Security number, or available, you can provide this
confidential business information, such information on the cover sheet and not
DEPARTMENT OF HEALTH AND as a manufacturing process. Please note in the body of your comments and you
HUMAN SERVICES that if you include your name, contact must identify this information as
information, or other information that ‘‘confidential.’’ Any information marked
Food and Drug Administration identifies you in the body of your as ‘‘confidential’’ will not be disclosed
[Docket No. FDA–2018–N–2027] comments, that information will be except in accordance with 21 CFR 10.20
posted on https://www.regulations.gov. and other applicable disclosure law. For
Agency Information Collection • If you want to submit a comment more information about FDA’s posting
Activities; Proposed Collection; with confidential information that you of comments to public dockets, see 80
Comment Request; Survey of Current do not wish to be made available to the FR 56469, September 18, 2015, or access
Manufacturing Practices for the public, submit the comment as a the information at: https://www.gpo.gov/
Cosmetics Industry written/paper submission and in the fdsys/pkg/FR-2015-09-18/pdf/2015-
manner detailed (see ‘‘Written/Paper 23389.pdf.
AGENCY: Food and Drug Administration, Submissions’’ and ‘‘Instructions’’). Docket: For access to the docket to
HHS.
Written/Paper Submissions read background documents or the
ACTION: Notice. electronic and written/paper comments
Submit written/paper submissions as received, go to https://
SUMMARY: The Food and Drug follows:
Administration (FDA, Agency, or we) is www.regulations.gov and insert the
• Mail/Hand delivery/Courier (for docket number, found in brackets in the
announcing an opportunity for public written/paper submissions): Dockets
comment on the proposed collection of heading of this document, into the
Management Staff (HFA–305), Food and ‘‘Search’’ box and follow the prompts
certain information by the Agency. Drug Administration, 5630 Fishers
Under the Paperwork Reduction Act of and/or go to the Dockets Management
Lane, Rm. 1061, Rockville, MD 20852. Staff, 5630 Fishers Lane, Rm. 1061,
1995 (PRA), Federal Agencies are • For written/paper comments
required to publish notice in the Rockville, MD 20852.
submitted to the Dockets Management
Federal Register concerning each FOR FURTHER INFORMATION CONTACT: Ila
Staff, FDA will post your comment, as
proposed collection of information and well as any attachments, except for S. Mizrachi, Office of Operations, Food
to allow 60 days for public comment in information submitted, marked and and Drug Administration, Three White
response to the notice. This notice identified, as confidential, if submitted Flint North, 10A–12M, 11601
solicits comments on a new information as detailed in ‘‘Instructions.’’ Landsdown St., North Bethesda, MD
collection: A survey of the cosmetics Instructions: All submissions received 20852, 301–796–7726, PRAStaff@
industry on their current manufacturing must include the Docket No. FDA– fda.hhs.gov.
practices. 2018–N–2027 for ‘‘Agency Information SUPPLEMENTARY INFORMATION: Under the
DATES: Submit either electronic or Collection Activities; Proposed PRA (44 U.S.C. 3501–3520), Federal
written comments on the collection of Collection; Comment Request; Survey of Agencies must obtain approval from the
information by August 31, 2018. Current Manufacturing Practices for the Office of Management and Budget
ADDRESSES: You may submit comments Cosmetics Industry.’’ Received (OMB) for each collection of
as follows. Please note that late, comments, those filed in a timely information they conduct or sponsor.
untimely filed comments will not be manner (see ADDRESSES), will be placed ‘‘Collection of information’’ is defined
considered. Electronic comments must in the docket and, except for those in 44 U.S.C. 3502(3) and 5 CFR
be submitted on or before August 31, submitted as ‘‘Confidential 1320.3(c) and includes Agency requests
2018. The https://www.regulations.gov Submissions,’’ publicly viewable at or requirements that members of the
electronic filing system will accept https://www.regulations.gov or at the public submit reports, keep records, or
comments until midnight Eastern Time Dockets Management Staff between provide information to a third party.
at the end of August 31, 2018. 9 a.m. and 4 p.m., Monday through Section 3506(c)(2)(A) of the PRA (44
Comments received by mail/hand Friday. U.S.C. 3506(c)(2)(A)) requires Federal
delivery/courier (for written/paper • Confidential Submissions—To Agencies to provide a 60-day notice in
submissions) will be considered timely submit a comment with confidential the Federal Register concerning each
if they are postmarked or the delivery information that you do not wish to be proposed collection of information
service acceptance receipt is on or made publicly available, submit your before submitting the collection to OMB
before that date. comments only as a written/paper for approval. To comply with this
submission. You should submit two requirement, FDA is publishing notice
Electronic Submissions copies total. One copy will include the of the proposed collection of
Submit electronic comments in the information you claim to be confidential information set forth in this document.
daltland on DSKBBV9HB2PROD with NOTICES
following way: with a heading or cover note that states With respect to the following
• Federal eRulemaking Portal: ‘‘THIS DOCUMENT CONTAINS collection of information, FDA invites
https://www.regulations.gov. Follow the CONFIDENTIAL INFORMATION.’’ The comments on these topics: (1) Whether
instructions for submitting comments. Agency will review this copy, including the proposed collection of information
Comments submitted electronically, the claimed confidential information, in is necessary for the proper performance
including attachments, to https:// its consideration of comments. The of FDA’s functions, including whether
www.regulations.gov will be posted to second copy, which will have the the information will have practical
VerDate Sep<11>2014 17:40 Jun 29, 2018 Jkt 244001 PO 00000 Frm 00032 Fmt 4703 Sfmt 4703 E:\FR\FM\02JYN1.SGM 02JYN1](https://thefederalregister.org/doc/83_FR_31065/page/3.svg)
Document Created: 2018-06-30 00:17:48
Document Modified: 2018-06-30 00:17:48
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| FR Citation | 83 FR 30938 |
2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR